Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “oxygen”

78 pharma patents match "oxygen" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 78
Index total 30,257
Page 1 / 4

Quick answer

This filtered view shows 78 pharmaceutical patents matching "oxygen" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

78 results for “oxygen” · 30,257 patents in full index Clear search

  1. US 12311029

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

    Northwestern University · Granted May 27, 2025 · Expires May 22, 2045

    granted
  2. US 12303618

    Oxygen-generating cryogels

    Northwestern University · Granted May 20, 2025 · Expires May 15, 2045

    granted
  3. US 12233103

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  4. US 12005194

    Configurable oxygen concentrator and related method

    SEPARATION DESIGN GROUP LLC · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  5. US 11884707

    Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  6. US 11878053

    Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof

    IO Biotech ApS · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  7. US 11839659

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

    Northwestern University · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  8. US 11648302

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted May 16, 2023 · Expires May 11, 2043

    granted
  9. US 11324813

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted May 10, 2022 · Expires May 5, 2042

    granted
  10. US 11274077

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    The United States of America Department of Health · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  11. US 11236044

    Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  12. US 11173145

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

    The Board of Regents of the University of Texas System · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  13. US 11147801

    Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  14. US 11078168

    Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

    Phenex Discovery Verwaltungs-GmbH · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  15. US 11061094

    Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange saturation transfer imaging (ME-CEST)

    The Regents of the University of California · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  16. US 11046649

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

    The Board of Regents of the University of Texas System · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  17. US 10953187

    Configurable oxygen concentrator and related method

    SEPARATION DESIGN GROUP LLC · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  18. US 10781183

    Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  19. US 10752581

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    The Regents of the University of California Santa · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  20. US 10561763

    Oxygen generating biomaterial

    The Board of Regents of the University of Texas System · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  21. US 10287279

    Inhibitors of human 12/15-lipoxygenase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted
  22. US 10266488

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted
  23. US 10258678

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted
  24. US 10202428

    Compositions and methods for the delivery of oxygen

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted